BSE filing, BSE: 543828. Summary written from the filing by ALFA Finder's alert engine.
Sudarshan Pharma Industries Ltd: key numbers
- Share price
- ₹38.00
- Market cap
- ₹914.5 Cr
- Revenue (annual)
- ₹703.1 Cr
- Net profit (annual)
- ₹23.30 Cr
- P/E (TTM)
- 39.2×Sector 34.5×
- Promoter holding
- 57.81%-1.12% QoQ
- FII holding
- 21.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sudarshan Pharma Industries Ltd
All →Sudarshan Pharma Industries Board Meeting Date
Sudarshan Pharma's board meets 29 October 2026 to consider Q2 results and a fund-raising proposal. Trading window remains closed until 48 hours after results.
Sudarshan Pharma Industries SME to Main Board Migration
Sudarshan Pharma's shares will list on NSE's main board from October 27, 2026, migrating from BSE SME. Trading begins under symbol SUDARSHAN, marking a platform upgrade.
Sudarshan Pharma Industries Other Announcement
Sudarshan Pharma Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Sudarshan Pharma Industries Merger & Restructuring
Sudarshan Pharma terminated its proposal to acquire 9.50% of Med Therapy Biotechnology Inc. The promoters' parallel 1.50% each acquisition plan also stands terminated.
Sudarshan Pharma Industries Merger & Restructuring Worth ₹1.4 Cr
Sudarshan Pharma Industries completed the sale of its 51% stake in subsidiary Ishwari Healthcare Private Limited for ₹1.40 Crore. The entity ceases to be a subsidiary.
- Value
- ₹1.40 Cr
Sudarshan Pharma Industries Annual General Meeting
Sudarshan Pharma Industries Ltd held its 18th Annual General Meeting on September 22, 2026. The meeting covered the adoption of financial statements and director re-appointment.
Other board meeting date announcements
All →Retaggio Industries Board Meeting Date
Retaggio Industries will hold a board meeting on 3 November 2026 to consider Q2 results. Trading window remains closed until 5 November 2026.
Finelistings Technologies Board Meeting Date
Finelistings Technologies will hold a board meeting on October 31, 2026 to consider unaudited results for the half year ended September 30, 2026. The filing is a prior intimation, so no results are yet approved.
Nityas Gems and Jewellery Board Meeting Date
Nityas Gems and Jewellery intimated a board meeting on 06 Nov 2026 to consider standalone and consolidated unaudited results for the quarter and half year ended 30 Sep 2026. The meeting has not yet been held.
TCI Industries Board Meeting Date
TCI Industries will hold a board meeting on November 3, 2026 to approve unaudited results for the quarter and half year ended September 30, 2026. The trading window for designated persons remains closed until 48 hours after the results announcement.
Kalind Board Meeting Date
Kalind Ltd will hold a Board meeting on 31 October 2026 to update on and decide the ongoing preferential issue of 8,60,86,956 equity shares. In-principle approval from BSE is still awaited.
Patidar Buildcon Board Meeting Date
Patidar Buildcon will hold a board meeting on 5 November 2026 to approve unaudited Q2 results for the quarter ended 30 September 2026. The trading window stays closed until 7 November 2026.